Steris

Steris helps hospitals and labs keep their tools clean and safe. It makes machines that kill germs on medical equipment for doctors. These products protect patients from infections during medical procedures.

Tools for a Cleaner World

• Healthcare products: Cleaning chemicals, surgical tables, and lights for hospitals and surgery centers.
• Sterilization services: Specialized cleaning and testing for medical device and pharmaceutical manufacturers.
• Life sciences gear: Washers and disinfectants used in pharmaceutical and biopharmaceutical manufacturing plants.

How Is Steris Growing?

• Divested the Dental segment in fiscal 2025 to focus on core healthcare markets.
• Increased the order backlog to $490.7 million by March 31, 2026, through new acquisitions.
• Expanded irradiation capacity using accelerator-based technology to improve global sterilization services.

Why Quality Comes First

The company runs a network of more than 50 sterilization facilities across the Americas, Europe, and Asia. It uses a harmonized global quality system to follow strict medical safety laws in every country.

Key Numbers for 2026

• Revenue reached $1.6 billion in Q4 2026, up 7.3% from Q4 2025.
• Net income hit $220.3 million in Q4 2026, up 50.4% year-over-year.
• Operating cash flow was $1.34 billion in fiscal 2026, up 16.8% from 2025.
• Free cash flow rose to $245.2 million in Q4 2026, up 29.1% from the previous year.

Bottom Line

Steris has shed non-core divisions to focus on high-stakes medical and pharmaceutical sterilization. This evolution positions the company as a vital infrastructure provider for global healthcare systems.